Portugal: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Portugal

In 2022, the Portuguese prophylactic medicaments containing insulin market decreased by -2.3% to $X, falling for the second year in a row after three years of growth. In general, the total consumption indicated a prominent expansion from 2012 to 2022: its value increased at an average annual rate of +5.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -14.1% against 2020 indices. Over the period under review, the market reached the maximum level at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Portugal

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported from Portugal rose markedly to X tons, surging by 6.8% on the previous year. In general, exports continue to indicate a buoyant increase. The pace of growth was the most pronounced in 2014 when exports increased by 68% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports reduced to $X in 2022. Over the period under review, exports, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 when exports increased by 84% against the previous year. As a result, the exports attained the peak of $X. From 2021 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

Angola (X tons), Germany (X tons) and Cabo Verde (X tons) were the main destinations of prophylactic medicaments containing insulin exports from Portugal, with a combined 69% share of total exports. France, the Netherlands, the United Arab Emirates, the Czech Republic and the UK lagged somewhat behind, together comprising a further 30%.

From 2012 to 2022, the biggest increases were recorded for France (with a CAGR of +76.4%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest markets for prophylactic medicaments containing insulin exported from Portugal were Angola ($X), Germany ($X) and the Netherlands ($X), together accounting for 70% of total exports. Cabo Verde, the Czech Republic, the United Arab Emirates, France and the UK lagged somewhat behind, together comprising a further 24%.

France, with a CAGR of +100.1%, recorded the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, declining by -13.1% against the previous year. Overall, the export price continues to indicate a abrupt shrinkage. The most prominent rate of growth was recorded in 2020 an increase of 37%. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Kuwait (+29.8%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Portugal

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -5.3% to X tons, falling for the second year in a row after five years of growth. Overall, imports, however, showed a remarkable increase. The pace of growth appeared the most rapid in 2014 with an increase of 56% against the previous year. Over the period under review, imports attained the maximum at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports amounted to $X in 2022. Over the period under review, total imports indicated perceptible growth from 2012 to 2022: its value increased at an average annual rate of +3.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -12.8% against 2020 indices. The most prominent rate of growth was recorded in 2013 when imports increased by 42% against the previous year. Over the period under review, imports reached the peak figure at $X in 2014; however, from 2015 to 2022, imports remained at a lower figure.

Imports by Country

Germany (X tons), France (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Portugal, with a combined 93% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by France (with a CAGR of +28.7%), while imports for the other leaders experienced more modest paces of growth.

In value terms, France ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Portugal, comprising 49% of total imports. The second position in the ranking was taken by Denmark ($X), with a 22% share of total imports. It was followed by Germany, with a 16% share.

From 2012 to 2022, the average annual rate of growth in terms of value from France amounted to +36.8%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (-7.2% per year) and Germany (-1.1% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, picking up by 6.1% against the previous year. Overall, the import price, however, recorded a deep contraction. The pace of growth was the most pronounced in 2013 an increase of 9.2% against the previous year. As a result, import price attained the peak level of $X per ton. From 2014 to 2022, the average import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Italy ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+6.3%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :